Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 20, 2022

SELL
$2.66 - $6.63 $43,858 - $109,315
-16,488 Closed
0 $0
Q4 2021

Feb 16, 2022

BUY
$6.07 - $12.0 $36,450 - $72,060
6,005 Added 57.28%
16,488 $100,000
Q3 2021

Nov 12, 2021

SELL
$6.79 - $13.9 $54,903 - $112,395
-8,086 Reduced 43.55%
10,483 $74,000
Q2 2021

Aug 12, 2021

BUY
$9.43 - $16.6 $44,019 - $77,488
4,668 Added 33.58%
18,569 $255,000
Q1 2021

May 03, 2021

SELL
$9.71 - $18.6 $2,845 - $5,449
-293 Reduced 2.06%
13,901 $149,000
Q4 2020

Feb 12, 2021

BUY
$3.91 - $12.28 $55,498 - $174,302
14,194 New
14,194 $172,000

About Evelo Biosciences, Inc.


  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.